Clinical Trial Update: Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS [Phase 2]

View source ↗

Summary

This Phase 2 trial studied selective T-cell depletion in stem cell transplantation to reduce graft-versus-host disease. It included patients with leukemia, lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Syndromes

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Graft vs Host Disease, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2012-01-13